Big Pharma CEOs get a face-to-face with Trump and a shot at a negotiated cease fire
On Monday, as CEOs in the biotech industry chimed in to criticize Donald Trump’s travel ban for 7 Muslim countries, the top figures from Big Pharma were notably silent. None of the CEOs of the top 10 companies offered a word of protest, and the companies that chose to say anything largely limited themselves to reassuring worried staffers of their support. Brent Saunders at Allergan was the only head of a major company to voice his disapproval.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.